Can AI Really Design New Drugs? Google DeepMind Spin-out Isomorphic Labs Explains

Can AI move from predicting proteins to actually designing new drugs? Isomorphic Labs is trying to answer one of the biggest questions in science.

In this episode of The Neuron, Corey Noles and Grant Harvey talk with Rebecca Paul, Head of Medicinal Drug Design at Isomorphic Labs, and Michael Schaarschmidt, Foundational AI Research Lead.

They explain why drug discovery is so slow, expensive, and failure-prone—and why AI drug design is much more complicated than “generate a molecule and ship it.” The conversation covers AlphaFold, structure prediction, molecule generation, binding models, clinical failure rates, human trust in AI systems, and the long-term hope of designing drugs for targets once considered “undruggable.”

In this episode:

Why drug discovery can take more than a decade
What people misunderstand about “AI-designed drugs”
How medicinal chemists actually use AI models
Why biology is harder than text, images, or code
What it would take to make drug discovery faster and cheaper
The dream of designing a drug candidate in one iteration
Why “undruggable” proteins may not stay undruggable forever

Additional resources:

Technical report blog Best resource for learning about the capabilities that we are building
Isomorphic Labs websiteBest destination for learning more about Iso and joining our team in London, Lausanne or Cambridge, MA

Subscribe for more grounded conversations on how AI is changing science, work, and the world.

For more practical, grounded conversations on AI systems that actually work, subscribe to The Neuron newsletter at https://theneuron.ai.

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(126)

BONUS: OpenClaw 2.0 with Chief Architect Vincent Koc

OpenClaw 2.0 just landed, and we’re going straight to the person helping build it. 🦞This week on The Neuron LIVE, Vincent Koc, Chief Architect of OpenClaw, joins us for a hands-on look at the biggest...

25 Sep 1h 19min

Inside CoreWeave’s AI Infrastructure With Chen Goldberg

AI infrastructure used to be the part developers were supposed to forget about. What happens when the infrastructure itself starts determining what AI can doCorey Noles sits down with Chen Goldberg, E...

23 Sep 39min

BONUS: A Beginner’s Guide to GitHub, LIVE with Cassidy Williams

UPDATE: Blog version here https://theneuron.ai/explainer-articles/github-for-beginners-how-to-use-it-with-ai-coding-agents/GitHub can feel intimidating if you didn’t come up as a developer, especially...

18 Sep 1h 58min

GPT-6 Astra One-Shot Demos

Corey and Grant put GPT-6 Astra through six identical one-shot build tests to see what it can create with almost no follow-up instruction. The episode covers an interactive black hole lab, a Blender s...

16 Sep 1h 5min

BONUS: Apple’s AI Era Starts Now? Meta’s Free AI Agent + OpenAI’s $1M Math Fight

We’re going LIVE after Apple’s biggest event of the year to break down John Ternus’s first major keynote as CEO and the big question: Is Apple finally entering its AI era?We’ll unpack what Apple revea...

11 Sep 1h 35min

OpenAI Astra, Local AI, and the Hardware Race

What happens when AI models get powerful enough that the bottleneck stops being the model, and starts becoming the computer, the power grid, or the safeguards around it?Corey Noles and Grant Harvey br...

9 Sep 1h 34min

BONUS: Claude Fable 5.1 LIVE: Testing Anthropic’s New AI Agent

Anthropic just released Claude Fable 5.1, its newest frontier model for long-running coding, research, and agentic work.So naturally, we’re putting it to the test LIVE. 🤖Early testing suggests Fable ...

4 Sep 1h

Where Does AI Agent Security Actually Live?

AI companies spend enormous effort making models safer, but the model tested in the lab isn't necessarily the system a company eventually deploys. Alice CEO and co-founder Noam Schwartz joins Corey an...

28 Aug 54min